Clinical Gastroenterology and Hepatology

Pancreatic panniculitis
Aourag M, Tjwa ETTL and Te Groen M
ENDOSCOPIC SEDATION TYPE DURING FLIP PANOMETRY DOES NOT SIGNIFICANTLY IMPACT FLIP MOTILITY CLASSIFICATION RELATIVE TO MANOMETRY
Pezzino EC, Pandolfino JE, Toaz E, Kahrilas PJ and Carlson DA
Functional lumen imaging probe (FLIP) Panometry evaluates esophageal motility at the time of sedated endoscopy and often parallels high-resolution manometry (HRM) performed in awake patients. This study aimed to assess the impact of endoscopic sedation on FLIP evaluation of esophageal motility.
Prognostic Communication, Symptom Burden, Psychological Distress, and Quality of Life Among Patients with Decompensated Cirrhosis
Donlan J, Kaplan A, Noll A, Pintro K, Horick N, Zeng C, Edelen M, Soetan Z, Comrie C, Indriolo T, Li L, Zhu E, Armstrong ME, Thompson LL, Zhou J, Diop MS, Mason N, Engel KG, Rowland M, Kenimer S, O'Brien K, Lai JC, Jackson V, Chung RT, El-Jawahri A and Ufere NN
Timely prognostic communication is a critical component of care for patients with decompensated cirrhosis (DC). However, few studies have examined the association of prognostic communication with symptoms, mood, and health-related quality of life (HRQOL) in this population.
Influence of comorbidities on health-related quality of life in alcohol-related liver disease: a population-based survey
Elde KD, Jepsen P, Von Wowern N, Winther-Jensen M, Eliasen MH, Christensen AI, Madsen LG and Askgaard G
Extra-hepatic comorbidities are common in alcohol-related liver disease (ALD). We examined associations between burden of comorbidities, alcohol, and smoking with low health-related quality of life (HRQoL) among patients with ALD.
Yield and Effectiveness of Two-Sample Fecal Immunochemical Test-based Screening Program for Colorectal Cancer
Xu Z, Yang J, He J, Li Q, Fei X, Bai H, Gao K, He Y, Li C, Tang M, Wang J, Jin M and Chen K
Colorectal cancer (CRC) incidence and mortality of China account for nearly 30% of the global attributable fraction. We aimed to estimate the yield and effectiveness of two-sample fecal immunochemical test (FIT)-based screening program in China.
Switch from Off-Label Swallowed Topical Corticosteroids to Budesonide Orodispersible Tablets in Eosinophilic Esophagitis patients
Pellegatta G, Giugliano FP, Mastrorocco E, Ilaria B, Hassan C and Repici A
Food Swamps and Food Deserts Impact on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Mortality in US Counties
Paik A, Henry L, De Avila L, AlQahtani S, Nader F, Paik JM and Younossi ZM
Lacking access to quality food may increase the risk of MASLD. We investigated associations between food environment factors (food deserts and food swamps) and MASLD-related mortality across the United States (US).
Identification of Candidates for MASLD Treatment with Indeterminate Vibration-Controlled Transient Elastography
Marti-Aguado D, Carot-Sierra JM, Villalba-Ortiz A, Siddiqi H, Vallejo-Vigo RM, Lara-Romero C, Martín-Fernández M, Fernández-Patón M, Alfaro-Cervello C, Crespo A, Coello E, Merino-Murgui V, Madamba E, Benlloch S, Pérez-Rojas J, Puglia V, Ferrández A, Aguilera V, Monton C, Escudero-García D, Lluch P, Aller R, Loomba R, Romero-Gomez M and Marti-Bonmati L
A noteworthy proportion of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) have an indeterminate vibration-controlled transient elastography (VCTE). Among these patients, we aimed to identify candidates for MASLD treatment by diagnosing significant fibrosis.
Daily or twice daily treatment with topical steroids results in similar responses in eosinophilic esophagitis
Reed CC, LaFata SS, Gee TS, Thel HL, Cameron BA, Xue AZ, Kiran A, Ocampo AA, McCallen J, Lee CJ, Borinsky SA, Redd WD, Barlowe T, Kaakati RN, Cotton CC, Eluri S and Dellon ES
Few data compare topical corticosteroid (tCS) dosing regimens and outcomes. We aimed to compare treatment outcomes in eosinophilic esophagitis (EoE) patients by once or twice daily dosing regimens.
A predictive model based on quantitative fecal immunochemical test can stratify the risk of CRC in an organized screening program
Frazzoni L, Pecere S, Hassan C, Fuccio L, Del Vecchio LE, Fabbri C, Arrigoni A, Cassoni P, Mazzucco D, Orione L, Gibiino G, Repici A, Spada C, Iacopini F, Senore C and Antonelli G
A significant number of post-faecal immunochemical test (FIT) colonoscopies in European organized colorectal cancer (CRC) screening programs are performed beyond the recommended 31-day threshold due to overburdened colonoscopy services. We aimed to develop a simple predictive model to stratify CRC risk of FIT+ patients.
Risk of incident cancer in patients with Inflammatory Bowel Disease with prior breast cancer: a multicenter cohort study
Le Cosquer G, Kirchgesner J, Gilletta De Saint Joseph C, Seksik P, Amiot A, Laharie D, Nachury M, Rouillon C, Abitbol V, Nuzzo A, Nancey S, Fumery M, Biron A, Richard N, Altwegg R, Moussata D, Caron B, Vidon M, Reenaers C, Uzzan M, Reimund JM, Serrero M, Simon M, Benezech A, Goutorbe F, Pelletier AL, Caillo L, Vaysse C, Poullenot F and
Breast cancer is the most common malignancy observed in patients with inflammatory bowel diseases (IBD). The aim of our study was to evaluate incident cancer rate (recurrence or new-onset cancer) in a cohort of IBD patients with a history of breast cancer according to the subsequent IBD treatment provided.
Dietary antioxidant capacity, genetic susceptibility and polymorphism, and inflammatory bowel disease risk in a prospective cohort
Chen J, Dan L, Yuan S, Fu T, Sun J, Wolk A, Ludvigsson JF, Li X, Wang X and Larsson SC
Oxidative stress is an essential factor in the pathogenesis of inflammatory bowel disease (IBD). A previous study found protective potential of some antioxidative nutrients against IBD. However, the association between total antioxidant capacity (TAC) of the diet and incident IBD is unclear.
The role of piecemeal endoscopic mucosal resection for low risk larget than 20 mm nonpedunculated polyps in the right colon
Murino A, Rimondi A and Despott EJ
Older age but not comorbidity is associated with worse survival in patients with hepatocellular carcinoma
Kanneganti M, Al-Hasan M, Bourque S, Deodhar S, Yang JD, Huang DQ, Kulkarni AV, Gopal P, Parikh ND, Kanwal F, Patel MS and Singal AG
Age and comorbidity are key factors in assessing patient prognosis and informing stopping rules for cancer screening eligibility, but their impact has not been rigorously evaluated in patients with hepatocellular carcinoma (HCC).
Peripheral tumor necrosis factor production is a predictor for remission under adalimumab in Crohn's disease
Jessen B, T Tordai M, and Siegmund B
Artificial Intelligence Chatbots Not Yet Ready for Celiac Disease Patient Care
Jansson-Knodell CL, Gardinier D, Weekley K, Yang Q and Rubio-Tapia A
Non-invasive hepatic steatosis and fibrosis indices predict differentially mortality in the adult Korean population
Seo YG, Polyzos SA, Park KH and Mantzoros CS
Since the association of hepatic fibrosis and steatosis non-invasive indices with mortality remain controversial, their association with all-cause, cardiovascular, cancer and liver-related mortality was evaluated in the Korean population.
Prevalence of Gastroparesis in Chronic Pancreatitis and Predictive Factors: A Machine Learning Prediction Model
Ramai D, Pan CW, Troendle DM, Maida M, Facciorusso A, Machicado JD and
Secondhand Smoke Exposure and Metabolic Dysfunction-Associated Steatotic Liver Disease in US Adolescents
Kim D, Perumpail BJ, Danpanichkul P, Wijarnpreecha K and Ahmed A
Anti-integrin αvβ6 autoantibodies are increased in PSC patients with concomitant IBD and correlate with liver disease severity
Bloemen H, Livanos AE, Martins A, Dean R, Bravo AC, Bourgonje AR, Tankelevich M, Herb J, Cho J, Santos AA, Rodrigues CMP, Petralia F, Colombel JF, Bowlus CL, Schiano T, Torres J, Levy C and Mehandru S
Anti-integrin αvβ6 autoantibodies (anti-αvβ6) are found in more than 50% of individuals with ulcerative colitis (UC). We aimed to determine the prevalence of anti-αvβ6 in patients with primary sclerosing cholangitis (PSC) and their association with liver disease severity.
Unveiling the Hidden Cost: Evaluating Financial Implications in the Liver Cancer Screening Paradigm
Aby ES and Ufere NN